Demographic characteristics | Stroke | t/χ2/Z | P | |
---|---|---|---|---|
Yes (n = 798) | No (n = 2671) | |||
Gender | ||||
Women, n (%) | 305 (38.22) | 825 (30.89) | 15.04 | < 0.01 |
Men, n (%) | 493 (61.78) | 1846 (69.11) | ||
Age, year | 71.64 ± 9.96 | 67.30 ± 12.01 | −10.28 | < 0.01 |
Body mass index, kg/m2 | 25.20 ± 3.26 | 24.75 ± 3.35 | −3.35 | < 0.01 |
Hypertension, n (%) | 352 (44.11) | 907 (33.96) | 27.39 | < 0.01 |
Diabetes mellitus,n (%) | 171 (21.43) | 531 (19.88) | 0.91 | 0.34 |
Heart failure, n (%) | 424 (53.13) | 1510 (56.53) | 2.88 | 0.09 |
Vascular disease, n (%) | 121 (15.16) | 263 (9.85) | 17.64 | < 0.01 |
CHA2DS2-VASc score, mean | 4.96 ± 1.37 | 2.47 ± 1.40 | −44.45 | < 0.01 |
Smoking, n (%) | 269 (33.71) | 660 (24.71) | 25.38 | < 0.01 |
Drinking, n (%) | 124 (15.54) | 371 (13.89) | 1.37 | 0.24 |
TG, mmol/L | 1.11 ± 0.67 | 1.14 ± 0.89 | 1.08 | 0.28 |
TC, mmol/L | 3.57 ± 1.29 | 3.48 ± 1.47 | −1.55 | 0.12 |
non-HDL-C, mmol/L | 2.65 ± 1.25 | 2.48 ± 1.42 | −3.10 | < 0.01 |
LDL-C, mmol/L | 2.58 ± 1.02 | 1.69 ± 0.86 | −22.18 | < 0.01 |
HDL-C, mmol/L | 0.92 ± 0.39 | 1.00 ± 0.34 | 5.47 | < 0.01 |
LDL-C/HDL-C | 2.83 (1.83, 4.09) | 1.55 (1.10, 2.27) | −22.17 | < 0.01 |
Uric acid, umol/L | 278.54 ± 147.06 | 295.71 ± 145.64 | 2.92 | < 0.01 |
Creatinine, mmol/L | 75.44 ± 37.23 | 76.00 ± 59.92 | 0.32 | 0.75 |
Blood urea nitrogen, mmol/L | 5.97 ± 2.68 | 6.05 ± 2.77 | 0.67 | 0.50 |
Fasting plasma glucose, mmol/L | 5.93 ± 2.44 | 5.75 ± 2.29 | −1.92 | 0.06 |
Previous Medications | ||||
Anti-hypertensive drugs, n (%) | 287 (35.96) | 754 (28.23) | 17.51 | < 0.01 |
Anti-diabetic agents, n (%) | 141 (17.67) | 420 (15.72) | 1.71 | 0.19 |
Statins, n (%) | 85 (10.65) | 345 (12.92) | 2.90 | 0.09 |
anti-platelet drugs, n (%) | 150 (18.80) | 583 (21.83) | 3.39 | 0.07 |
anticoagulant drugs, n (%) | 189 (23.68) | 656 (24.56) | 0.26 | 0.61 |